Barclays Maintains Overweight on Cemex, Lowers Price Target to $8
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Benjamin Theurer maintains an Overweight rating on Cemex (NYSE:CX) but lowers the price target from $9 to $8.
October 29, 2024 | 12:44 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Barclays has maintained its Overweight rating on Cemex but has reduced the price target from $9 to $8, indicating a slightly less optimistic outlook.
The maintenance of an Overweight rating suggests continued confidence in Cemex's performance, but the lowered price target indicates a tempered outlook, likely leading to a slight negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100